Binding and Antigen Presentation of Ceramide-Containing Glycolipids by Soluble Mouse and Human Cd1d Molecules

Olga V. Naidenko(La Jolla Institute for Immunology), Juli K. Maher(La Jolla Institute for Immunology), William Ernst(University of California, Los Angeles), Teruyuki Sakai(Kirin (Japan)), Robert L. Modlin(University of California, Los Angeles), Mitchell Kronenberg(La Jolla Institute for Immunology)
The Journal of Experimental Medicine
October 18, 1999
Cited by 150Open Access
Full Text

Abstract

We have purified soluble mouse and human CD1d molecules to assess the structural requirements for lipid antigen presentation by CD1. Plate-bound CD1d molecules from either species can present the glycolipid alpha-galactosyl ceramide (alpha-GalCer) to mouse natural killer T cells, formally demonstrating both the in vitro formation of antigenic complexes, and the presentation of alpha-GalCer by these two CD1d molecules. Using surface plasmon resonance, we show that at neutral pH, mouse CD1 and human CD1d bind to immobilized alpha-GalCer, unlike human CD1b, which requires acidic pH for lipid antigen binding. The CD1d molecules can also bind both to the nonantigenic beta-GalCer and to phosphatidylethanolamine, indicating that diverse lipids can bind to CD1d. These studies provide the first quantitative analysis of monomeric lipid antigen-CD1 interactions, and they demonstrate that the orientation of the galactose, or even the nature of the polar head group, are likely to be more important for T cell receptor contact than CD1d binding.


Related Papers

No related papers found

Powered by citation graph analysis